Title: Big Pharma Backs Joe Biden, But People Don’t Think He’ll Fix Drug Pricing
By Darragh Roche
Former Vice President Joe Biden is winning the race for donations from Big Pharma but experts and industry stakeholders doubt his plans will successfully lower drug prices or address underlying issues in the industry.
The pharmaceuticals and health products industry has donated more than $5.9 million to Biden’s presidential campaign, according to OpenSecrets.org, a site run by the Center for Responsive Politics, which tracks political donations. . .
. . . Dr. Wayne Winegarden of the Pacific Research Institute, a free market think tank, told Newsweek the executive order could harm patients.
“There are many problems with President Trump’s most favored nation executive order,” Winegarden said. “He fails to understand the drivers of the drug affordability problem, and his EO will harm patients, innovation, and could ironically increase overall healthcare spending.” . . .